| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 124 | 2024 | 8304 | 3.700 |
Why?
|
| Dementia | 39 | 2023 | 2545 | 3.000 |
Why?
|
| Apolipoproteins E | 25 | 2022 | 1418 | 1.590 |
Why?
|
| Apolipoprotein E4 | 15 | 2022 | 684 | 1.570 |
Why?
|
| Cognition Disorders | 33 | 2017 | 3954 | 1.470 |
Why?
|
| Genetic Linkage | 21 | 2008 | 2365 | 1.250 |
Why?
|
| Flavonoids | 2 | 2021 | 441 | 1.250 |
Why?
|
| Cognition | 22 | 2024 | 6773 | 1.110 |
Why?
|
| Neuropsychological Tests | 39 | 2022 | 6931 | 1.060 |
Why?
|
| Amyloid beta-Peptides | 11 | 2024 | 3742 | 0.820 |
Why?
|
| alpha-Macroglobulins | 5 | 2007 | 63 | 0.750 |
Why?
|
| Bupropion | 1 | 2022 | 302 | 0.740 |
Why?
|
| Stroke | 14 | 2023 | 9693 | 0.700 |
Why?
|
| Genotype | 30 | 2020 | 12773 | 0.650 |
Why?
|
| Brain | 26 | 2024 | 26596 | 0.630 |
Why?
|
| Cerebrovascular Disorders | 5 | 2023 | 1484 | 0.600 |
Why?
|
| Aged | 135 | 2024 | 164236 | 0.580 |
Why?
|
| Leukoaraiosis | 1 | 2018 | 115 | 0.560 |
Why?
|
| Microvessels | 1 | 2018 | 567 | 0.470 |
Why?
|
| Epilepsy | 5 | 2022 | 3277 | 0.470 |
Why?
|
| Cholinesterase Inhibitors | 4 | 2013 | 236 | 0.460 |
Why?
|
| Inheritance Patterns | 3 | 2013 | 332 | 0.450 |
Why?
|
| Psychiatric Status Rating Scales | 13 | 2017 | 5982 | 0.440 |
Why?
|
| Humans | 222 | 2024 | 746044 | 0.430 |
Why?
|
| Aged, 80 and over | 77 | 2024 | 57557 | 0.430 |
Why?
|
| Electronic Health Records | 7 | 2023 | 4558 | 0.420 |
Why?
|
| Caregivers | 9 | 2022 | 2139 | 0.420 |
Why?
|
| Diet | 4 | 2022 | 7881 | 0.420 |
Why?
|
| Polymorphism, Genetic | 12 | 2009 | 4275 | 0.410 |
Why?
|
| Longitudinal Studies | 31 | 2024 | 14113 | 0.400 |
Why?
|
| Genetic Testing | 13 | 2019 | 3477 | 0.400 |
Why?
|
| Antipsychotic Agents | 5 | 2022 | 3053 | 0.400 |
Why?
|
| Genetic Predisposition to Disease | 32 | 2019 | 17434 | 0.390 |
Why?
|
| Aging | 13 | 2024 | 8486 | 0.370 |
Why?
|
| Models, Statistical | 10 | 2021 | 5027 | 0.370 |
Why?
|
| Hypertension | 5 | 2024 | 8358 | 0.360 |
Why?
|
| Apolipoprotein E2 | 2 | 2007 | 129 | 0.360 |
Why?
|
| Male | 128 | 2024 | 351093 | 0.360 |
Why?
|
| Female | 131 | 2024 | 382109 | 0.350 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 933 | 0.350 |
Why?
|
| Lod Score | 10 | 2011 | 596 | 0.330 |
Why?
|
| Interview, Psychological | 3 | 2011 | 800 | 0.330 |
Why?
|
| Diet Surveys | 3 | 2022 | 1150 | 0.330 |
Why?
|
| Nuclear Family | 7 | 2006 | 311 | 0.320 |
Why?
|
| Age of Onset | 21 | 2015 | 3241 | 0.310 |
Why?
|
| Peptide Fragments | 3 | 2018 | 5032 | 0.310 |
Why?
|
| Indans | 2 | 2006 | 92 | 0.310 |
Why?
|
| Temporal Lobe | 8 | 2017 | 1690 | 0.300 |
Why?
|
| Chromosome Mapping | 11 | 2011 | 4612 | 0.300 |
Why?
|
| Memory | 5 | 2020 | 2165 | 0.280 |
Why?
|
| Gene Frequency | 14 | 2017 | 3532 | 0.280 |
Why?
|
| Models, Genetic | 9 | 2011 | 3423 | 0.280 |
Why?
|
| Lipid Metabolism | 2 | 2019 | 1875 | 0.270 |
Why?
|
| Cerebral Hemorrhage | 4 | 2022 | 2617 | 0.260 |
Why?
|
| tau Proteins | 3 | 2024 | 2013 | 0.260 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2602 | 0.250 |
Why?
|
| Risk Factors | 37 | 2024 | 72416 | 0.250 |
Why?
|
| Social Participation | 3 | 2021 | 175 | 0.240 |
Why?
|
| Cohort Studies | 29 | 2022 | 40503 | 0.240 |
Why?
|
| Activities of Daily Living | 7 | 2021 | 2379 | 0.240 |
Why?
|
| Blood Pressure | 6 | 2023 | 8404 | 0.240 |
Why?
|
| Middle Aged | 63 | 2024 | 214412 | 0.230 |
Why?
|
| Pedigree | 11 | 2015 | 4555 | 0.220 |
Why?
|
| Chromosomes, Human | 3 | 2011 | 442 | 0.220 |
Why?
|
| Anticonvulsants | 3 | 2021 | 1867 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 25 | 2022 | 35784 | 0.220 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 1886 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 18 | 2018 | 15366 | 0.220 |
Why?
|
| Disease Progression | 17 | 2021 | 13303 | 0.220 |
Why?
|
| Bipolar Disorder | 7 | 2006 | 5051 | 0.210 |
Why?
|
| Apathy | 1 | 2024 | 106 | 0.210 |
Why?
|
| Delirium | 3 | 2022 | 1633 | 0.210 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2017 | 868 | 0.210 |
Why?
|
| Genetic Loci | 3 | 2019 | 2554 | 0.210 |
Why?
|
| Linkage Disequilibrium | 13 | 2017 | 1963 | 0.210 |
Why?
|
| Genetic Markers | 11 | 2023 | 2593 | 0.200 |
Why?
|
| Seizures | 3 | 2022 | 2880 | 0.200 |
Why?
|
| Haplotypes | 6 | 2020 | 2722 | 0.200 |
Why?
|
| Exercise | 1 | 2018 | 5686 | 0.200 |
Why?
|
| Depression | 7 | 2019 | 7826 | 0.200 |
Why?
|
| International Classification of Diseases | 3 | 2022 | 868 | 0.190 |
Why?
|
| Mental Recall | 5 | 2014 | 1195 | 0.190 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2012 | 1153 | 0.190 |
Why?
|
| Meat Products | 1 | 2021 | 96 | 0.190 |
Why?
|
| Memantine | 2 | 2013 | 106 | 0.190 |
Why?
|
| United States | 34 | 2022 | 70383 | 0.180 |
Why?
|
| Infarction | 1 | 2022 | 247 | 0.180 |
Why?
|
| National Institute of Mental Health (U.S.) | 5 | 2011 | 105 | 0.180 |
Why?
|
| Educational Status | 5 | 2022 | 2483 | 0.180 |
Why?
|
| Hypotension, Orthostatic | 1 | 2023 | 251 | 0.180 |
Why?
|
| Vitamin E | 1 | 2005 | 869 | 0.180 |
Why?
|
| Alleles | 13 | 2020 | 6831 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 10 | 4 | 2007 | 276 | 0.180 |
Why?
|
| Entorhinal Cortex | 3 | 2017 | 278 | 0.170 |
Why?
|
| Cross-Sectional Studies | 17 | 2024 | 25177 | 0.170 |
Why?
|
| Piperidines | 2 | 2006 | 1634 | 0.170 |
Why?
|
| Genetics, Medical | 2 | 2005 | 336 | 0.170 |
Why?
|
| DNA Methylation | 2 | 2024 | 4258 | 0.170 |
Why?
|
| Genome-Wide Association Study | 11 | 2023 | 12202 | 0.170 |
Why?
|
| Neurofibrillary Tangles | 2 | 2021 | 445 | 0.170 |
Why?
|
| Medicare | 8 | 2022 | 6553 | 0.170 |
Why?
|
| Teaching Rounds | 1 | 2023 | 271 | 0.170 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2011 | 953 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2000 | 277 | 0.160 |
Why?
|
| Parkinson Disease | 2 | 2023 | 2815 | 0.160 |
Why?
|
| Parietal Lobe | 3 | 2008 | 850 | 0.160 |
Why?
|
| Quantitative Trait Loci | 4 | 2011 | 2025 | 0.160 |
Why?
|
| Predictive Value of Tests | 13 | 2017 | 15009 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2017 | 2881 | 0.160 |
Why?
|
| Proportional Hazards Models | 11 | 2017 | 12273 | 0.160 |
Why?
|
| Brain Ischemia | 2 | 2022 | 3072 | 0.160 |
Why?
|
| Positron-Emission Tomography | 5 | 2024 | 6420 | 0.160 |
Why?
|
| Age Factors | 11 | 2021 | 18146 | 0.150 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 247 | 0.150 |
Why?
|
| Mental Status Schedule | 7 | 2014 | 313 | 0.150 |
Why?
|
| Preoperative Care | 2 | 2017 | 2218 | 0.150 |
Why?
|
| Case-Control Studies | 15 | 2020 | 21673 | 0.150 |
Why?
|
| Alcoholism | 4 | 2004 | 1921 | 0.150 |
Why?
|
| Hypotension | 1 | 2023 | 863 | 0.150 |
Why?
|
| Geriatric Assessment | 4 | 2016 | 1367 | 0.150 |
Why?
|
| Genome, Human | 4 | 2008 | 4356 | 0.150 |
Why?
|
| Algorithms | 12 | 2023 | 13796 | 0.150 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 124 | 0.140 |
Why?
|
| Research Design | 6 | 2021 | 6056 | 0.140 |
Why?
|
| Fibrinolytic Agents | 2 | 2012 | 2135 | 0.140 |
Why?
|
| Nootropic Agents | 2 | 2010 | 155 | 0.140 |
Why?
|
| Causality | 3 | 2023 | 1232 | 0.140 |
Why?
|
| Atrophy | 8 | 2017 | 1613 | 0.140 |
Why?
|
| Family | 9 | 2008 | 3156 | 0.140 |
Why?
|
| Dietary Proteins | 1 | 2022 | 939 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1174 | 0.140 |
Why?
|
| Exons | 3 | 2001 | 2387 | 0.140 |
Why?
|
| Decision Support Techniques | 2 | 2021 | 1958 | 0.140 |
Why?
|
| Olfactory Perception | 1 | 2016 | 63 | 0.140 |
Why?
|
| Folic Acid | 1 | 2023 | 1284 | 0.140 |
Why?
|
| Follow-Up Studies | 18 | 2023 | 38752 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1997 | 244 | 0.140 |
Why?
|
| Netherlands | 2 | 2020 | 2180 | 0.130 |
Why?
|
| Memory Disorders | 5 | 2011 | 1175 | 0.130 |
Why?
|
| Demography | 4 | 2014 | 1629 | 0.130 |
Why?
|
| Probability | 2 | 2023 | 2468 | 0.130 |
Why?
|
| Plaque, Amyloid | 3 | 2016 | 740 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 1057 | 0.130 |
Why?
|
| Antidepressive Agents | 2 | 2022 | 2864 | 0.130 |
Why?
|
| Cerebral Cortex | 5 | 2011 | 5716 | 0.130 |
Why?
|
| Cost of Illness | 3 | 2014 | 1878 | 0.130 |
Why?
|
| Amyloid | 3 | 2022 | 811 | 0.130 |
Why?
|
| Cardiovascular Diseases | 5 | 2015 | 15308 | 0.130 |
Why?
|
| Abbreviations as Topic | 1 | 2014 | 8 | 0.130 |
Why?
|
| Metformin | 1 | 2022 | 875 | 0.130 |
Why?
|
| Reproducibility of Results | 11 | 2022 | 19804 | 0.120 |
Why?
|
| Remote Consultation | 1 | 1997 | 228 | 0.120 |
Why?
|
| Amyloidosis | 1 | 2022 | 803 | 0.120 |
Why?
|
| Hippocampus | 6 | 2016 | 3685 | 0.120 |
Why?
|
| Lewy Body Disease | 2 | 2008 | 246 | 0.120 |
Why?
|
| Odds Ratio | 8 | 2022 | 9596 | 0.120 |
Why?
|
| Depressive Disorder | 5 | 2019 | 3716 | 0.120 |
Why?
|
| Reference Values | 5 | 2008 | 4875 | 0.120 |
Why?
|
| Antisocial Personality Disorder | 2 | 2006 | 225 | 0.120 |
Why?
|
| Telephone | 1 | 1997 | 619 | 0.120 |
Why?
|
| Social Behavior Disorders | 1 | 2014 | 96 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2007 | 432 | 0.110 |
Why?
|
| Task Performance and Analysis | 2 | 2007 | 755 | 0.110 |
Why?
|
| Conduct Disorder | 2 | 2006 | 239 | 0.110 |
Why?
|
| Dementia, Vascular | 1 | 2014 | 123 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 2009 | 528 | 0.110 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2015 | 1100 | 0.110 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2012 | 28 | 0.110 |
Why?
|
| Telomere | 1 | 2019 | 905 | 0.110 |
Why?
|
| Trypsinogen | 1 | 2012 | 84 | 0.110 |
Why?
|
| Immunity | 1 | 2019 | 995 | 0.110 |
Why?
|
| Databases, Genetic | 3 | 2011 | 1731 | 0.110 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 3661 | 0.110 |
Why?
|
| Health Care Costs | 5 | 2009 | 3186 | 0.100 |
Why?
|
| Patient Preference | 1 | 2020 | 891 | 0.100 |
Why?
|
| Diseases in Twins | 2 | 2004 | 448 | 0.100 |
Why?
|
| Adult | 26 | 2022 | 214958 | 0.100 |
Why?
|
| Linear Models | 5 | 2017 | 5821 | 0.100 |
Why?
|
| Genetic Heterogeneity | 3 | 2011 | 714 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 3896 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2021 | 23453 | 0.100 |
Why?
|
| Psychometrics | 4 | 2013 | 2993 | 0.100 |
Why?
|
| Receptors, Immunologic | 2 | 2017 | 1415 | 0.100 |
Why?
|
| Trypsin | 1 | 2012 | 493 | 0.100 |
Why?
|
| Claudins | 1 | 2012 | 113 | 0.100 |
Why?
|
| Prospective Studies | 13 | 2023 | 53218 | 0.100 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 20 | 0.100 |
Why?
|
| Menarche | 1 | 2014 | 527 | 0.100 |
Why?
|
| Incidence | 6 | 2023 | 20812 | 0.100 |
Why?
|
| Australia | 1 | 2014 | 1214 | 0.090 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1994 | 772 | 0.090 |
Why?
|
| Brain Diseases | 1 | 2020 | 1541 | 0.090 |
Why?
|
| Adolescent Development | 1 | 2014 | 276 | 0.090 |
Why?
|
| Membrane Proteins | 3 | 2011 | 7785 | 0.090 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 1 | 2010 | 24 | 0.090 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2014 | 1951 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2013 | 447 | 0.090 |
Why?
|
| Receptors, Complement 3b | 1 | 2010 | 136 | 0.090 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 799 | 0.090 |
Why?
|
| Time Factors | 10 | 2021 | 39587 | 0.090 |
Why?
|
| Phenotype | 7 | 2020 | 16245 | 0.090 |
Why?
|
| Clusterin | 1 | 2010 | 71 | 0.090 |
Why?
|
| Body Weight | 1 | 2021 | 4590 | 0.090 |
Why?
|
| Psychotic Disorders | 3 | 2018 | 3100 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 3 | 2005 | 4394 | 0.090 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 280 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2000 | 2964 | 0.090 |
Why?
|
| Models, Psychological | 3 | 2009 | 802 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 2190 | 0.080 |
Why?
|
| Heterozygote | 3 | 2007 | 2764 | 0.080 |
Why?
|
| Statistics as Topic | 3 | 2011 | 2339 | 0.080 |
Why?
|
| Home Health Aides | 1 | 2008 | 15 | 0.080 |
Why?
|
| Logistic Models | 8 | 2021 | 13164 | 0.080 |
Why?
|
| Microglia | 1 | 2017 | 1310 | 0.080 |
Why?
|
| Patient Selection | 1 | 2021 | 4191 | 0.080 |
Why?
|
| Severity of Illness Index | 10 | 2014 | 15537 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2012 | 965 | 0.080 |
Why?
|
| Statistics, Nonparametric | 5 | 2008 | 2841 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2012 | 1601 | 0.080 |
Why?
|
| Brain Mapping | 6 | 2011 | 6594 | 0.080 |
Why?
|
| ROC Curve | 2 | 2014 | 3496 | 0.080 |
Why?
|
| Leisure Activities | 1 | 2009 | 303 | 0.080 |
Why?
|
| Hormone Replacement Therapy | 1 | 2013 | 742 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3290 | 0.070 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 1250 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3417 | 0.070 |
Why?
|
| Self-Assessment | 1 | 2009 | 382 | 0.070 |
Why?
|
| alpha Catenin | 1 | 2007 | 37 | 0.070 |
Why?
|
| Gene Dosage | 2 | 2012 | 1221 | 0.070 |
Why?
|
| Hormones | 1 | 2011 | 873 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2014 | 4926 | 0.070 |
Why?
|
| Prevalence | 8 | 2021 | 15308 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2005 | 448 | 0.070 |
Why?
|
| Physical Chromosome Mapping | 1 | 2007 | 182 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2000 | 5746 | 0.070 |
Why?
|
| Advisory Committees | 1 | 2011 | 768 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2005 | 375 | 0.070 |
Why?
|
| Pattern Recognition, Visual | 3 | 2007 | 816 | 0.070 |
Why?
|
| Asthma | 2 | 2006 | 6109 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2007 | 264 | 0.070 |
Why?
|
| Pneumonia | 2 | 2015 | 2110 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2014 | 966 | 0.070 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2007 | 305 | 0.070 |
Why?
|
| Twin Studies as Topic | 1 | 2005 | 104 | 0.060 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2005 | 28 | 0.060 |
Why?
|
| 3' Untranslated Regions | 2 | 2005 | 520 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2023 | 8370 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 1348 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2008 | 1068 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2017 | 3017 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2005 | 135 | 0.060 |
Why?
|
| Cause of Death | 1 | 2015 | 3615 | 0.060 |
Why?
|
| Eating | 2 | 2022 | 1531 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2008 | 622 | 0.060 |
Why?
|
| Postmenopause | 1 | 2013 | 2461 | 0.060 |
Why?
|
| Cathepsin D | 2 | 2001 | 60 | 0.060 |
Why?
|
| Data Collection | 3 | 2012 | 3287 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 7935 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2678 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2007 | 4010 | 0.060 |
Why?
|
| Delusions | 1 | 2005 | 296 | 0.050 |
Why?
|
| Terminology as Topic | 2 | 2006 | 1529 | 0.050 |
Why?
|
| Europe | 2 | 2020 | 3354 | 0.050 |
Why?
|
| Regression Analysis | 4 | 2011 | 6332 | 0.050 |
Why?
|
| Hallucinations | 1 | 2005 | 357 | 0.050 |
Why?
|
| Natural Language Processing | 2 | 2022 | 1080 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2012 | 2072 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 635 | 0.050 |
Why?
|
| Self Report | 3 | 2024 | 3589 | 0.050 |
Why?
|
| Executive Function | 1 | 2011 | 1335 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3153 | 0.050 |
Why?
|
| Syndrome | 2 | 2006 | 3245 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2011 | 8901 | 0.050 |
Why?
|
| Epidemiologic Methods | 1 | 2007 | 1337 | 0.050 |
Why?
|
| Homozygote | 2 | 2020 | 1767 | 0.050 |
Why?
|
| Vitamin B 6 | 1 | 2023 | 228 | 0.050 |
Why?
|
| Focus Groups | 1 | 2007 | 1336 | 0.050 |
Why?
|
| Proxy | 1 | 2022 | 148 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2004 | 474 | 0.050 |
Why?
|
| Public Health | 1 | 2014 | 2624 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 2042 | 0.050 |
Why?
|
| Movement Disorders | 1 | 2005 | 460 | 0.050 |
Why?
|
| Home Care Services | 1 | 2008 | 625 | 0.050 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 5238 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2022 | 150 | 0.050 |
Why?
|
| Sulfonylurea Compounds | 1 | 2022 | 217 | 0.050 |
Why?
|
| Insulysin | 1 | 2000 | 49 | 0.050 |
Why?
|
| Aniline Compounds | 2 | 2017 | 1043 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2008 | 1808 | 0.050 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2000 | 40 | 0.050 |
Why?
|
| Dizziness | 1 | 2023 | 243 | 0.050 |
Why?
|
| Software | 5 | 2006 | 4399 | 0.050 |
Why?
|
| Mathematical Computing | 1 | 2001 | 143 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2003 | 525 | 0.050 |
Why?
|
| Patient Care | 1 | 2006 | 620 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2022 | 229 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 3751 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2011 | 3898 | 0.050 |
Why?
|
| Medical Informatics | 1 | 2007 | 728 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2014 | 14537 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2008 | 6220 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2012 | 6453 | 0.040 |
Why?
|
| Smoking | 3 | 2023 | 8975 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 2002 | 292 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2023 | 517 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3269 | 0.040 |
Why?
|
| Computer Simulation | 3 | 2007 | 6146 | 0.040 |
Why?
|
| Information Dissemination | 2 | 2021 | 1113 | 0.040 |
Why?
|
| Motivation | 1 | 2009 | 1963 | 0.040 |
Why?
|
| Intracranial Thrombosis | 1 | 2000 | 109 | 0.040 |
Why?
|
| Autopsy | 2 | 2014 | 995 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 3306 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2011 | 3789 | 0.040 |
Why?
|
| State Medicine | 1 | 2021 | 218 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 385 | 0.040 |
Why?
|
| Gene Expression | 1 | 2012 | 7580 | 0.040 |
Why?
|
| Thiazoles | 2 | 2017 | 1487 | 0.040 |
Why?
|
| Apolipoproteins | 1 | 2021 | 317 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2005 | 2614 | 0.040 |
Why?
|
| Ultrasonic Therapy | 1 | 2000 | 217 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11940 | 0.040 |
Why?
|
| Brief Psychiatric Rating Scale | 2 | 2008 | 107 | 0.040 |
Why?
|
| Germany | 1 | 2001 | 857 | 0.040 |
Why?
|
| Meat | 1 | 2021 | 576 | 0.040 |
Why?
|
| Presenilin-2 | 1 | 1998 | 95 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2014 | 12633 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 942 | 0.040 |
Why?
|
| Speech | 1 | 2022 | 536 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 968 | 0.040 |
Why?
|
| Narration | 1 | 2020 | 212 | 0.040 |
Why?
|
| Organ Size | 2 | 2017 | 2239 | 0.040 |
Why?
|
| Siblings | 3 | 2007 | 819 | 0.040 |
Why?
|
| Magnetics | 1 | 2000 | 599 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 3426 | 0.040 |
Why?
|
| Panic Disorder | 2 | 2002 | 607 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2007 | 10127 | 0.040 |
Why?
|
| Reference Standards | 1 | 2021 | 1001 | 0.040 |
Why?
|
| Medical Records | 1 | 2022 | 1390 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 2002 | 662 | 0.040 |
Why?
|
| Reading | 1 | 2021 | 551 | 0.040 |
Why?
|
| Hospitals, University | 2 | 2009 | 566 | 0.030 |
Why?
|
| Genes | 1 | 2000 | 1841 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2022 | 1112 | 0.030 |
Why?
|
| Prognosis | 6 | 2017 | 29068 | 0.030 |
Why?
|
| Dysthymic Disorder | 1 | 1996 | 74 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2000 | 611 | 0.030 |
Why?
|
| Institutionalization | 2 | 2007 | 105 | 0.030 |
Why?
|
| Disclosure | 1 | 2022 | 731 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1760 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3327 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 626 | 0.030 |
Why?
|
| Mothers | 1 | 2006 | 2160 | 0.030 |
Why?
|
| Ethylene Glycols | 1 | 2017 | 185 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 1999 | 984 | 0.030 |
Why?
|
| Massachusetts | 2 | 2021 | 8593 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15341 | 0.030 |
Why?
|
| New Jersey | 1 | 2015 | 289 | 0.030 |
Why?
|
| Independent Living | 1 | 2019 | 558 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2020 | 2258 | 0.030 |
Why?
|
| Video Recording | 1 | 2020 | 943 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2021 | 1520 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2007 | 350 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2021 | 1694 | 0.030 |
Why?
|
| Nerve Net | 1 | 2006 | 2210 | 0.030 |
Why?
|
| Age Distribution | 1 | 2020 | 2842 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2021 | 1223 | 0.030 |
Why?
|
| Presenilin-1 | 1 | 1998 | 635 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 604 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7271 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2006 | 2439 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2000 | 1419 | 0.030 |
Why?
|
| Energy Intake | 1 | 2021 | 2114 | 0.030 |
Why?
|
| Fiji | 1 | 2013 | 47 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2017 | 467 | 0.030 |
Why?
|
| DNA | 3 | 2003 | 7199 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2021 | 1980 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 3408 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 5458 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2020 | 959 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 2766 | 0.030 |
Why?
|
| Psychiatry | 1 | 2005 | 1683 | 0.030 |
Why?
|
| Family Health | 3 | 2004 | 1255 | 0.030 |
Why?
|
| Inflammation | 1 | 2012 | 10592 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2018 | 1010 | 0.030 |
Why?
|
| Health Status | 2 | 2021 | 4016 | 0.030 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 1144 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2014 | 224 | 0.030 |
Why?
|
| Bayes Theorem | 2 | 2011 | 2272 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 128 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2008 | 12018 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 1367 | 0.020 |
Why?
|
| Monte Carlo Method | 2 | 2011 | 1266 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2010 | 63661 | 0.020 |
Why?
|
| Visual Perception | 1 | 2020 | 1374 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2014 | 466 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 12839 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 3820 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2014 | 547 | 0.020 |
Why?
|
| Association | 1 | 2011 | 47 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6453 | 0.020 |
Why?
|
| Morbidity | 1 | 1996 | 1743 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2002 | 2677 | 0.020 |
Why?
|
| Adolescent | 7 | 2018 | 86202 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 1294 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2023 | 78297 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2011 | 234 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2023 | 3324 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2022 | 3026 | 0.020 |
Why?
|
| Acute Disease | 1 | 2000 | 7116 | 0.020 |
Why?
|
| Insurance Claim Review | 1 | 2014 | 722 | 0.020 |
Why?
|
| Socioeconomic Factors | 3 | 2008 | 7673 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2009 | 4119 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2005 | 4670 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3655 | 0.020 |
Why?
|
| Sex Factors | 2 | 2014 | 10279 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4335 | 0.020 |
Why?
|
| Residence Characteristics | 2 | 2011 | 2004 | 0.020 |
Why?
|
| Health Behavior | 1 | 2021 | 2596 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2009 | 255 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2004 | 3666 | 0.020 |
Why?
|
| Decision Making | 1 | 2022 | 3855 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2010 | 757 | 0.020 |
Why?
|
| Mental Disorders | 2 | 2005 | 6637 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9521 | 0.020 |
Why?
|
| Cleft Lip | 1 | 2013 | 490 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2013 | 959 | 0.020 |
Why?
|
| Quality of Life | 1 | 2009 | 12984 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2008 | 287 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 17675 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 1075 | 0.020 |
Why?
|
| Mass Screening | 1 | 2023 | 5329 | 0.020 |
Why?
|
| Comorbidity | 3 | 2009 | 10351 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2009 | 644 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2009 | 364 | 0.020 |
Why?
|
| Prosopagnosia | 1 | 2008 | 62 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 1994 | 1255 | 0.020 |
Why?
|